1126 - 1150 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
-
RESTRICTEDTitle: Epigenetic Landscape of Parkinson’s Disease: Emerging Role in Disease Mechanisms and Therapeutic ModalitiesJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0211-8Best OA location URL: https://europepmc.org/articles/pmc3805874?pdf=renderCitation Count: 73
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
RESTRICTEDTitle: Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 148End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0497-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0497-4.pdfCitation Count: 74
-
RESTRICTEDTitle: The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 764End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0296-8Best OA location URL: https://europepmc.org/articles/pmc4391386?pdf=renderCitation Count: 17
-
RESTRICTEDTitle: Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 635End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0449-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0449-z.pdfCitation Count: 17
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
-
RESTRICTEDTitle: Emerging Targeted Therapeutics for Genetic Subtypes of ParkinsonismJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1378End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00920-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00920-8.pdfCitation Count: 27
-
RESTRICTEDTitle: Nucleic Acid–Based Therapeutics for Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 45
-
RESTRICTEDTitle: Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and RetentionJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1724End Page: 1735Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00960-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00960-0.pdfCitation Count: 37
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
- Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments2020RESTRICTEDTitle: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1681End Page: 1693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00914-6.pdfCitation Count: 58
-
RESTRICTEDTitle: Manganism in the 21st century: The Hanninen lectureJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 45Issue #:Start Page: 201End Page: 207Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2013.09.007Best OA location URL: https://europepmc.org/articles/pmc3992192?pdf=renderCitation Count: 65
-
RESTRICTEDTitle: Cell therapy in Parkinson’s diseaseJournal Name: NeuroRXPublisher: Springer Science and Business Media LLCVol: 1Issue #: 4Start Page: 382End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1602/neurorx.1.4.382Best OA location URL: https://link.springer.com/content/pdf/10.1602%2Fneurorx.1.4.382.pdfCitation Count: 334
-
RESTRICTEDTitle: Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 103Issue #:Start Page: 305End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.neubiorev.2019.05.016Best OA location URL: http://manuscript.elsevier.com/S0149763419300284/pdf/S0149763419300284.pdfCitation Count: 95
-
RESTRICTEDTitle: The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?Journal Name: The NeuroscientistPublisher: SAGE PublicationsVol: 26Issue #: 5-6Start Page: 503End Page: 520Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1073858420916696Best OA location URL: https://europepmc.org/articles/pmc8447404?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Finding useful biomarkers for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 454Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aam6003Best OA location URL: https://europepmc.org/articles/pmc6097233?pdf=renderCitation Count: 119
-
RESTRICTEDTitle: Alpha-synuclein oligomers: a new hopeJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 134Issue #: 6Start Page: 819End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1755-1Best OA location URL: https://europepmc.org/articles/pmc5663814?pdf=renderCitation Count: 255
- Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies2018RESTRICTEDTitle: Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 3Start Page: 363End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-018-1941-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-018-1941-9.pdfCitation Count: 6
-
RESTRICTEDTitle: Selective vulnerability in α-synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 138Issue #: 5Start Page: 681End Page: 704Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-02010-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-02010-2.pdfCitation Count: 59
-
RESTRICTEDTitle: Periphery and brain, innate and adaptive immunity in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 4Start Page: 527End Page: 545Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02268-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02268-5.pdfCitation Count: 147
-
RESTRICTEDTitle: Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challengesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 145Issue #: 5Start Page: 515End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02557-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02557-1.pdfCitation Count: 22
-
RESTRICTEDTitle: Epigenetic regulation in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 132Issue #: 4Start Page: 515End Page: 530Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-016-1590-9Best OA location URL: https://europepmc.org/articles/pmc5026906?pdf=renderCitation Count: 84
-
RESTRICTEDTitle: Neuroimaging of Freezing of GaitJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 5Issue #: 2Start Page: 241End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-150536Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150536?id=journal-of-parkinsons-disease%2Fjpd150536Citation Count: 90
-
RESTRICTEDTitle: Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease ProjectJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 10Start Page: e0292180End Page: e0292180Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0292180Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292180&type=printableCitation Count: 0